Testing effectiveness (Phase 2)Active Not RecruitingNCT04632108
What this trial is testing
A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors
Who this might be right for
Malignant Solid Tumor
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 199